Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting
Shining a spotlight on Clinical Study Software at the 2024 Pinnacle 21 Enterprise User Group Meeting
On October 30, 2024, we hosted our Pinnacle 21 Enterprise (P21E) User Group Meeting (UGM)…
CertaraNovember 12, 2024
4 Ways to Optimize Agency Partnerships Using a Platform-Oriented Approach
In the pharmaceutical and medical devices industries, the journey from product development to market introduction…
CertaraNovember 8, 2024
The Future of DIDB
Explore the future of the Drug Interaction Database (DIDB) in this on-demand webinar, featuring insights…
CertaraNovember 8, 2024
Why Clinical Pharmacology & Pharmacometrics Should Collaborate
A symbiosis between a modeler and a trialist is often required to develop a model-informed…
CertaraNovember 8, 2024
Comprehensive and Customized Toxicology Services
Comprehensive overview of toxicology services.
CertaraNovember 7, 2024
Certara Reports Third Quarter 2024 Financial Results
Updates Full Year 2024 Financial Guidance RADNOR, PA — November 6, 2024-- Certara, Inc. (Nasdaq: CERT),…
CertaraNovember 6, 2024
How Modeling Was Used to Support the FDA Approval of a Topical Generic Drug Product
Establishing bioequivalence for topical drug products can be challenging and costly, often requiring extensive comparative…
CertaraNovember 5, 2024
